262 related articles for article (PubMed ID: 30305026)
1. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes.
Han BW; Ye H; Wei PP; He B; Han C; Chen ZH; Chen YQ; Wang WT
BMC Genomics; 2018 Oct; 19(1):735. PubMed ID: 30305026
[TBL] [Abstract][Full Text] [Related]
2. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner.
Wang WT; Ye H; Wei PP; Han BW; He B; Chen ZH; Chen YQ
J Hematol Oncol; 2016 Nov; 9(1):117. PubMed ID: 27809873
[TBL] [Abstract][Full Text] [Related]
3. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1.
Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642
[TBL] [Abstract][Full Text] [Related]
4. Functions and roles of long noncoding RNA in cholangiocarcinoma.
Li J; Huang L; Li Z; Zhong X; Tai S; Jiang X; Cui Y
J Cell Physiol; 2019 Aug; 234(10):17113-17126. PubMed ID: 30888066
[TBL] [Abstract][Full Text] [Related]
5. Coding-noncoding gene expression in intrahepatic cholangiocarcinoma.
Wang J; Xie H; Ling Q; Lu D; Lv Z; Zhuang R; Liu Z; Wei X; Zhou L; Xu X; Zheng S
Transl Res; 2016 Feb; 168():107-121. PubMed ID: 26297049
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
[TBL] [Abstract][Full Text] [Related]
7. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide identification of a competing endogenous RNA network in cholangiocarcinoma.
Li G; Liu T; Zhang B; Chen W; Ding Z
J Cell Biochem; 2019 Nov; 120(11):18995-19003. PubMed ID: 31270845
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
[TBL] [Abstract][Full Text] [Related]
10. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of long noncoding RNA-associated competing endogenous RNA network in cholangiocarcinoma.
Song W; Miao DL; Chen L
Biochem Biophys Res Commun; 2018 Dec; 506(4):1004-1012. PubMed ID: 30404735
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells.
Zhang C; Li JY; Tian FZ; Zhao G; Hu H; Ma YF; Yang YL
Oncol Res; 2018 Jul; 26(6):879-888. PubMed ID: 28810932
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
Xu Y; Wang Z; Jiang X; Cui Y
Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
Li Y; Cai Q; Li W; Feng F; Yang L
Biochem Biophys Res Commun; 2018 Oct; 504(4):654-659. PubMed ID: 30205958
[TBL] [Abstract][Full Text] [Related]
16. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y
Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of long noncoding RNA and mRNA co-expression profile in intrahepatic cholangiocarcinoma tissue by RNA sequencing.
Yang W; Li Y; Song X; Xu J; Xie J
Oncotarget; 2017 Apr; 8(16):26591-26599. PubMed ID: 28427159
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges.
Yang Y; Deng X; Li Q; Wang F; Miao L; Jiang Q
Cancer Commun (Lond); 2020 Dec; 40(12):655-680. PubMed ID: 33142045
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]